163 related articles for article (PubMed ID: 18058225)
1. Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients.
Lo AC; Kleer CG; Banerjee M; Omar S; Khaled H; Eissa S; Hablas A; Douglas JA; Alford SH; Merajver SD; Soliman AS
Breast Cancer Res Treat; 2008 Nov; 112(1):141-7. PubMed ID: 18058225
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco.
Soliman AS; Kleer CG; Mrad K; Karkouri M; Omar S; Khaled HM; Benider AL; Ayed FB; Eissa SS; Eissa MS; McSpadden EJ; Lo AC; Toy K; Kantor ED; Xiao Q; Hampton C; Merajver SD
Breast Dis; 2011-2012; 33(4):159-69. PubMed ID: 23001584
[TBL] [Abstract][Full Text] [Related]
3. Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patients.
Lo AC; Georgopoulos A; Kleer CG; Banerjee M; Omar S; Khaled H; Eissa S; Hablas A; Omar HG; Douglas JA; Merajver SD; Soliman AS
Breast; 2009 Feb; 18(1):55-9. PubMed ID: 19157876
[TBL] [Abstract][Full Text] [Related]
4. Reliability of medical records in diagnosing inflammatory breast cancer in Egypt.
Le L; Schairer C; Hablas A; Meza J; Watanabe-Galloway S; Ramadan M; Merajver SD; Seifeldin IA; Soliman AS
BMC Res Notes; 2017 Mar; 10(1):126. PubMed ID: 28302157
[TBL] [Abstract][Full Text] [Related]
5. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer.
Kleer CG; Zhang Y; Pan Q; Gallagher G; Wu M; Wu ZF; Merajver SD
Breast Cancer Res; 2004; 6(1):R110-5. PubMed ID: 14696649
[TBL] [Abstract][Full Text] [Related]
6. Population-based statistics for women diagnosed with inflammatory breast cancer (United States).
Wingo PA; Jamison PM; Young JL; Gargiullo P
Cancer Causes Control; 2004 Apr; 15(3):321-8. PubMed ID: 15090727
[TBL] [Abstract][Full Text] [Related]
7. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.
van Golen KL; Bao LW; Pan Q; Miller FR; Wu ZF; Merajver SD
Clin Exp Metastasis; 2002; 19(4):301-11. PubMed ID: 12090470
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
9. Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients.
Marrakchi R; Khadimallah I; Ouerhani S; Gamoudi A; Khomsi F; Bouzaine H; Benamor M; Bougatef K; Mnif S; Zitoun R; Benna F; Boussen H; Rahal K; Elgaaied AB
Cancer Invest; 2010 May; 28(4):399-407. PubMed ID: 20014943
[TBL] [Abstract][Full Text] [Related]
10. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.
van Golen KL; Wu ZF; Qiao XT; Bao LW; Merajver SD
Cancer Res; 2000 Oct; 60(20):5832-8. PubMed ID: 11059780
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory and Non-inflammatory Breast Cancer: A Potential Role for Detection of Multiple Viral DNAs in Disease Progression.
El-Shinawi M; Mohamed HT; Abdel-Fattah HH; Ibrahim SA; El-Halawany MS; Nouh MA; Schneider RJ; Mohamed MM
Ann Surg Oncol; 2016 Feb; 23(2):494-502. PubMed ID: 26508152
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of inflammatory breast cancer (IBC).
Anderson WF; Schairer C; Chen BE; Hance KW; Levine PH
Breast Dis; 2005-2006; 22():9-23. PubMed ID: 16735783
[TBL] [Abstract][Full Text] [Related]
13. Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia.
Schairer C; Soliman AS; Omar S; Khaled H; Eissa S; Ayed FB; Khalafallah S; Ayoub WB; Kantor ED; Merajver S; Swain SM; Gail M; Brown LM
Cancer Med; 2013 Apr; 2(2):178-84. PubMed ID: 23634285
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of the inflammatory breast cancer phenotype.
Houchens NW; Merajver SD
Oncology (Williston Park); 2008 Dec; 22(14):1556-61; discussion 1561, 1565-8, 1576. PubMed ID: 19198217
[TBL] [Abstract][Full Text] [Related]
15. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
Kleer CG; Griffith KA; Sabel MS; Gallagher G; van Golen KL; Wu ZF; Merajver SD
Breast Cancer Res Treat; 2005 Sep; 93(2):101-10. PubMed ID: 16187229
[TBL] [Abstract][Full Text] [Related]
16. Modeling and characterization of inflammatory breast cancer emboli grown in vitro.
Lehman HL; Dashner EJ; Lucey M; Vermeulen P; Dirix L; Van Laere S; van Golen KL
Int J Cancer; 2013 May; 132(10):2283-94. PubMed ID: 23129218
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.
Joglekar M; Elbezanti WO; Weitzman MD; Lehman HL; van Golen KL
J Cell Biochem; 2015 Jun; 116(6):923-33. PubMed ID: 25559359
[TBL] [Abstract][Full Text] [Related]
18. RhoC induces differential expression of genes involved in invasion and metastasis in MCF10A breast cells.
Wu M; Wu ZF; Kumar-Sinha C; Chinnaiyan A; Merajver SD
Breast Cancer Res Treat; 2004 Mar; 84(1):3-12. PubMed ID: 14999149
[TBL] [Abstract][Full Text] [Related]
19. [Inflammatory breast carcinoma: towards molecular characterization?].
Charafe-Jauffret E; Tarpin C; Ginestier C; Bertucci F; Penault-Llorca F; Xerri L; Birnbaum D; Viens P; Hassoun J; Jacquemier J
Ann Pathol; 2003 Dec; 23(6):564-9. PubMed ID: 15094594
[TBL] [Abstract][Full Text] [Related]
20. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
